Half-year report · Q2
4598.TEDINET S100USFO
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 40
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥916m | 2024-04-01 → 2024-09-30 | Standalone | Operating income |
| Operating income | −¥593m | 2023-04-01 → 2023-09-30 | Standalone | Operating income |
| Ordinary income | −¥916m | 2024-04-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥1.4bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥599m | 2023-04-01 → 2023-09-30 | Standalone | Ordinary income |
| Profit before tax | −¥916m | 2024-04-01 → 2024-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥599m | 2023-04-01 → 2023-09-30 | Standalone | Income before income taxes |
| Net income | −¥917m | 2024-04-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥600m | 2023-04-01 → 2023-09-30 | Standalone | Profit loss |
| Total assets | ¥426m | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥491m | at 2023-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥110m | at 2024-09-30 | Standalone | Liabilities |
| Total liabilities | ¥241m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥316m | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥403m | at 2023-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥349m | at 2024-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥349m | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥437m | at 2023-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥844m | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥619m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥207,000 | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥918,000 | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.9bn | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥211m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-111.44 | 2024-04-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-198.78 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-91.92 | 2023-04-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.9% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.8% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 8,229,900 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,229,900 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,544,600 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 319
| Item | Context | Value | Unit |
|---|---|---|---|
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Type1 semi annual financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、中間連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration_NonConsolidatedMember | Original text (Japanese)当社は、医薬品事業のみの単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |